An open-label phase II study to evaluate PT2977 for the treatment of von hippel-lindau disease associated renal cell carcinoma

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii328
Main Authors Jonasch, E., Park, E., Thamake, S., Hirmand, M., Srinivasan, R.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy283.130